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Integration of two fluorescence imaging methods enables tracking of the formation of fibrillar Ab peptide
amyloid aggregates in neurons, as discussed by Esbjo¨rner and colleagues in this issue of Chemistry &
Biology. This approach has the potential to fundamentally improve our understanding of the onset and
therapeutic intervention of neurodegenerative diseases.A broad range of human diseases arises
from the failure of specific peptides or
proteins to fold correctly or to remain
correctly folded in their native func-
tional conformational state (Chiti and
Dobson, 2006). Neurodegenerative disor-
ders such as Alzheimer’s, Parkinson’s,
and Huntington’s diseases are all asso-
ciated with protein misfolding, aggrega-
tion, and the accumulation of insoluble
amyloid aggregates in neurons. There-
fore, characterization of aggregate spe-
cies and the direct observation of their
formation in cells are critical for under-
standing the mechanisms of neurodegen-
erative diseases and identifying potential
therapies. Traditional imaging tech-
niques, such as transmission electron
microscopy and atomic force micro-
scopy, are powerful, but they require
elaborate sample preparation protocols
and are difficult to apply dynamically
over extended periods of time, and their
invasive nature makes them unsuitable
for observations within living organisms.
Diffraction-limited fluorescence imaging
techniques with labeled protein mono-
mers and thioflavin T binding do not
suffer from these limitations and have
been used successfully to gain first in-
sights into amyloid fibril growth in cells
(Ban et al., 2004). In this issue of Chemis-
try & Biology, Esbjo¨rner et al. (2014) now
show that the combined application of
optical techniques can provide insight
into the temporal dimension for aggregate
formation, offering a new window on
neurodegeneration.
To investigate protein aggregation by
optical spectroscopy, one can take
advantage of the sensitivity of spectro-
scopic characteristics of fluorophores
to changes in their nanoenvironment. In
principle, each fluorophore reports aboutlocal changes in polarity, e.g., during
aggregation of labeled monomers mani-
fest changes to their absorption and
emission characteristics. Furthermore,
fluorophores start to communicate via
fluorescence resonance energy transfer
(FRET) when the interfluorophore dis-
tance decreases below 10 nm, giving
rise to homoFRET between identical re-
porter fluorophores or heteroFRET if a
mixture of donor- and acceptor-labeled
monomers are used. While homoFRET is
reflected in the depolarization of the
emitted fluorescence light, heteroFRET
can be monitored by quenching of the
donor fluorescence or by the rise of the
acceptor fluorescence on two spectrally
separated detection channels.
Recently, it was discovered that fluo-
rescently labeled Ab peptides exhibit a
substantial decrease in fluorescence life-
time upon aggregation and that this
correlates directly with the increase in b
sheet content as fibrillar amyloid struc-
tures are formed (Kaminski Schierle
et al., 2011a). Because homoFRET be-
tween identical fluorophores does not
alter the fluorescence lifetime, it was
postulated that energy transfer takes
place between the fluorophore labels
and acceptor energy states that develop
upon aggregation of the protein into
amyloids. Indeed, these studies led to
the discovery of energy states that absorb
energy corresponding to photons in the
visible range (Pinotsi et al., 2013; Chan
et al., 2013). Taking advantage of this
energy transfer effect, fluorescence life-
time imaging microscopy (FLIM) can be
used advantageously to monitor the
formation of amyloid aggregates by the
two most common isoforms of Ab
peptides, Aß(1–40) and Aß(1–42) in living
neurons (Esbjo¨rner et al., 2014). TheChemistry & Biology 21, June 19, 2014method is presently the only method
capable of tracking amyloid aggregation
kinetics directly in living cells with poten-
tial to shed light on the dynamics of Ab
assembly, which was identified as a cen-
tral and causative constituent of the
pathology of Alzheimer’s diseases, the
most prevalent form of adult dementia.
Esbjo¨rner et al. (2014) labeled the two
Aß isoforms with the fluorophore Hylite
Fluor 488 (HF488) and monitored the fluo-
rescence lifetime during their cellular
uptake and subsequent vesicular traf-
ficking within live neuronal cells. Indeed,
the fluorescence lifetime of both labeled
peptide monomers Aß(1–40) and Aß(1–
42) decreased considerably from an initial
3.7 ns to 3.3 ns as fibrillar species of
HF488 Aß peptides formed, decreasing
further to 2.5–3.0 ns for large HF488 Aß
aggregates. Proteolytic degradation of
the Aß aggregates restored the original
fluorescence lifetimes. To demonstrate
that the changes in the mean fluores-
cence lifetime reflect the kinetics of amy-
loid formation, the fluorescence lifetime
progression was observed upon addition
of a final concentration of 500 nM Aß pep-
tides to human neuroblastoma cells. A
membrane marker was used to demon-
strate that the peptides do not accumu-
late in the plasma membrane, but they
enter cells rapidly by endocytosis. After
24–48 hr, the peptides accumulate in
lysosomes as demonstrated by co-stain-
ing with a lysosomal marker. Interestingly,
the fluorescence lifetime measured for
Aß(1–42) decreased faster than for Aß(1–
40), whereas the endpoint lifetime is
similar for both peptides. These findings
demonstrate clear differences in aggrega-
tion kinetics and show that the self-as-
sembly of fluorescently labeled Aß(1–42)
peptides proceeds very efficiently withoutª2014 Elsevier Ltd All rights reserved 703
Figure 1. Combined FRET and dSTORMApproach toMonitor Amyloid Aggregate Formation and Size with Subdiffraction Optical Resolution
Monomers are labeled with green donor and red acceptor fluorophores. Upon cellular uptake at time t0, the average distance between donor- and acceptor-
labeled peptide monomers is too large to enable FRET. With increasing aggregation, the average donor/acceptor distance decreases, giving rise to the obser-
vation of FRET from the donor to the acceptor (t1). Continuing aggregation promotes FRET (t2) and enables dSTORM of red acceptor fluorophore signals (van de
Linde et al., 2013).
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due to the spatial confinement in lyso-
somes and prevailing acidic conditions.
In the next step, Esbjo¨rner et al. (2014)
used super-resolution fluorescence imag-
ing by direct stochastic optical re-
construction microscopy (dSTORM), a
previously introduced single-molecule
localization microcopy method based on
the photoswitching of standard fluores-
cent probes in the presence of thiols (Hei-
lemann et al., 2008; van de Linde et al.,
2013). This technique allowed them to
correlate the progression of the fluores-
cence lifetime decrease with the size of
amyloid aggregates. One- and dual-color
dSTORM has already been applied suc-
cessfully to investigate preassembled or
spontaneously formed amyloid fibrils
in fixed cells using fluorescently labeled
Aß peptides and antibodies (Kaminski
Schierle et al., 2011b) and the multi-
step aggregation process of a-synuclein,
whose aggregation is a characteristic
hallmark of Parkinson’s disease (Pinotsi
et al., 2014). In the new experiments by
Esbjo¨rner et al. (2014), dSTORM images
were taken after incubation of neuro-
blastoma cells with 500 nM fluoro-
phore-labeled Aß peptide monomer. The
obtained results corroborate the fluo-
rescence lifetime data, revealing that
Aß(1–42) aggregates exhibit an average
size along their longest dimension of704 Chemistry & Biology 21, June 19, 2014 ª225 nm at 24 hr after incubation and
do not further increase in size between
24and 48 hr. Also in accordance with the
fluorescence lifetime results, Aß(1–40)
aggregates grow more slowly, reaching
their final size only after 48 hr. Differences
found in aggregate shape and size inside
of cells and on bare coverslips indicate
the strong influence of spatial confine-
ment within intracellular compartments
on aggregate structure and formation
efficiency.
Altogether, the results demonstrate that
both FLIM and dSTORM can be used
as efficient complementary methods to
directly monitor the growth and absolute
size of amyloid aggregates in neurons.
Furthermore, the work highlights how the
refined understanding of the photophy-
sics of organic fluorophores and their
sensitive manipulation, even by small
changes in the nanoenvironment, can be
used advantageously for the develop-
ment of efficient fluorescence tools to
visualize protein assembly in fixed and
living cells. It is foreseeable that a com-
bined FRET and dSTORM strategy may
allow us to directly monitor aggregate for-
mation kinetics and subdiffraction aggre-
gate sizes simultaneously (Figure 1),
which would significantly enhance our
ability to understand the key events in
the development of neurodegenerative
diseases.2014 Elsevier Ltd All rights reservedREFERENCES
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